I would like to think that these continuing compliance problems are isolated solely within the sales organization of these pharmaceutical companies but I am afraid that is simply not the case. When you are a multi-Billion dollar a year company the pressure to produce is everywhere, not just in sales.
My sister in Law who works in drug development for a major pharmaceutical company has told me that even they often operate within a “Grey Area” that makes her uncomfortable. If you are on a team that continually fails at your attempts to produce a marketable product your job is in jeopardy just like it is if you don’t produce in sales. Would you be willing to fudge a number or two on a trial in order to get a product approved and keep your six figure income?
There are some drugs that should never even make it to stage 1 trials but the development team knows that even if it fails years later in later stage trials they don’t care because they are already working on a new product for the company.
My sister in Law who works in drug development for a major pharmaceutical company has told me that even they often operate within a “Grey Area” that makes her uncomfortable. If you are on a team that continually fails at your attempts to produce a marketable product your job is in jeopardy just like it is if you don’t produce in sales. Would you be willing to fudge a number or two on a trial in order to get a product approved and keep your six figure income?
There are some drugs that should never even make it to stage 1 trials but the development team knows that even if it fails years later in later stage trials they don’t care because they are already working on a new product for the company.